A life sciences accelerator called Blackbird Laboratories has $100 million to spend to turn Baltimore into a biotech hub.
Blackbird was founded at the start of this year with the backing of Baltimore Ravens owner Steve Bisciotti’s family foundation. So far, Blackbird has looked at about 80 to 100 proposals and funded five programs, Blackbird CEO Matt Tremblay told Endpoints News.